GRAIL presents preliminary Q4/FY2024 financial update at JPMorgan conference; specific figures not in excerpt

GRAIL, Inc.

2024-FY EPS reported -$63.54 revenue$125,595,000

Corporate update and preliminary Q4 and FY2024 financial results presented at J.P. Morgan Healthcare Conference on Jan 15, 2025.
Presentation furnished as Exhibit 99.1, but detailed financial figures are not provided in the filing text excerpt available.
CEO Bob Ragusa presented; full presentation may contain revenue, EPS, and other key metrics.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.